comparemela.com
Home
Live Updates
Milestone Pharmaceuticals Announces $125 Million Strategic F
Milestone Pharmaceuticals Announces $125 Million Strategic F
Milestone Pharmaceuticals Announces $125 Million Strategic Financing with RTW Investments to Support the Advancement of Etripamil for PSVT
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
Related Keywords
Ukraine ,
Russia ,
Canada ,
United States ,
Montreal ,
Quebec ,
Russian ,
Gibson Dunn ,
Amit Hasija ,
Broderick Wong ,
David Pitts ,
Exchange Commission ,
Drug Administration ,
Prnewswire Milestone Pharmaceuticals Inc ,
Milestone Pharmaceuticals ,
Nasdaq ,
Milestone Pharmaceuticals Inc ,
Corporate Development At Milestone ,
Us Securities Exchange Commission ,
New Drug Application ,
Managing Partner ,
Chief Investment Officer ,
Chief Financial Officer ,
Executive Vice President ,
Corporate Development ,
Securities Act ,
New York Based ,
Private Securities Litigation Reform Act ,
Nc ,